Galantamine attenuates autoinflammation in a mouse model of familial mediterranean fever
Open Access
- 9 December 2022
- journal article
- research article
- Published by Springer Nature in Molecular Medicine
- Vol. 28 (1) , 1-11
Abstract
Background: Autoinflammatory diseases, a diverse group of inherited conditions characterized by excessive innate immune activation, have limited therapeutic options. Neuroimmune circuits of the inflammatory reflex control innate immune overactivation and can be stimulated to treat disease using the acetylcholinesterase inhibitor galantamine. Methods: We tested the efficacy of galantamine in a rodent model of the prototypical autoinflammatory disease familial Mediterranean fever (FMF). Multiple chronic disease markers were evaluated in animals that received long-term galantamine treatment compared to vehicle. Results: Long-term treatment with galantamine attenuated the associated splenomegaly and anemia which are characteristic features of this disease. Further, treatment reduced inflammatory cell infiltration into affected organs and a subcutaneous air pouch. Conclusions: These findings suggest that galantamine attenuates chronic inflammation in this mouse model of FMF. Further research is warranted to explore the therapeutic potential of galantamine in FMF and other autoinflammatory diseases.Keywords
This publication has 47 references indexed in Scilit:
- Interleukin‐6 myokine signaling in skeletal muscle: a double‐edged sword?The FEBS Journal, 2013
- Rivastigmine Alleviates Experimentally Induced Colitis in Mice and Rats by Acting at Central and Peripheral Sites to Modulate Immune ResponsesPLOS ONE, 2013
- The pro- and anti-inflammatory properties of the cytokine interleukin-6Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Gain-of-Function Pyrin Mutations Induce NLRP3 Protein-Independent Interleukin-1β Activation and Severe Autoinflammation in MiceImmunity, 2011
- Chronic inflammation in FMF: markers, risk factors, outcomes and therapyNature Reviews Rheumatology, 2010
- Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory DiseaseAnnual Review of Immunology, 2009
- Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemiaProceedings of the National Academy of Sciences of the United States of America, 2008
- An update on the pharmacology of galantamineExpert Opinion on Investigational Drugs, 2007
- Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammationNature, 2002
- Galanthamine: pharmacokinetics, tissue distribution and cholinesterase inhibition in brain of miceNeuropharmacology, 1991